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tendon homeostasis such as expression of important extracellular matrix
components (collagen type I, elastin), matrix degrading enzymes (MMP-1,
-3) and to evaluate tenocyte inﬂammatory response by investigation
of pro-inﬂammatory (TNF-alpha, Il-1beta) and immunoregulatory (Il-6)
cytokine as well as suppressors of cytokine signalling (SOCS1, SOCS3)
expression.
Methods: Cultured primary human tenocytes were investigated for en-
dogen Il-10 and Il-10 receptor-1 (Il-10R1) expression as a prerequisite
for Il-10 signalling using RTD PCR and immunohistichemistry. Serum
starved tenocytes were treated with recombinant human Il-6, Il-10, TNF-
alpha or combinations of TNF-alpha with Il-6 and Il-10 (10 or 50 ng/mL,
24 h, 48 h). Expression of type I collagen, elastin, MMP-1, -3, TNF-
alpha, Il-1beta, Il-6, SOCS1 and SOCS3 was studied by RTD PCR,
immunohistochemistry or by western blot analysis.
Results: In the presence of TNF-alpha human tenocytes expressed
Il-10 and the Il-10 speciﬁc Il-10R1. Il-6 stimulated tenocyte collagen
type I expression at the protein level, but had obviously no effect on
elastin expression. TNF-alpha ampliﬁed slightly elastin expression, but
decreased type I collagen deposition.
TNF-alpha activated the tenocytes to highly up-regulate their gene
expression for matrix degrading enzymes (MMP-1, -3) as well as
pro-inﬂammatory (TNF-alpha, Il-1beta) and immunoregulatory cytokines
(Il-6). The treatment of tenocytes with recombinant Il-6 and Il-10 alone had
no major effect on their cytokine expression, the co-treatment with Il-6 or
Il-10 and TNF-alpha inhibited only slightly the expression of TNF-alpha,
Il-1beta and Il-6 in response to TNF-alpha. TNF-alpha stimulation, but
not the treatment with Il-6 or Il-10 augmented SOCS1, whereas SOCS3
gene expression was only up-regulated by Il-6 in tenocytes.
Conclusions: Tenocytes are able to express the immunoregulatory cy-
tokine Il-10 and its speciﬁc Il-10R1. However, the function of Il-10 in
tendon remains mainly unclear: Il-10 might play a role under inﬂammatory
conditions in tendon.
The results of the study indicate inﬂammatory, catabolic, but also distinct
anabolic effects of TNF-alpha which strongly activates the tenocytes
to produce several pro-inﬂammatory and immunoregulatory cytokines,
matrix degrading enzymes, suppresses collagen type I deposition but,
however, increases elastin expression. The observed induction of SOCS1
by TNF-alpha was not sufﬁcient to inhibit the TNF-alpha up-regulation
mediated by TNF-alpha. The multiple roles of TNF-alpha in tendon remod-
elling and the modulatory inﬂuence of Il-6 and Il-10 under inﬂammatory
conditions have to be further analysed.
Pain: Clinical
465 MODERATE TO SEVERE OSTEOARTHRITIS, BUT NO PAIN
D. Schiphof, B.M. de Klerk, J. Damen, B.W. Koes, H.A. Pols,
S.M. Bierma-Zeinstra. Erasmus MC, Rotterdam, NETHERLANDS
Purpose: It is known that there is discordance between pathological
evidence of osteoarthritis (OA), seen with radiographs, and clinical symp-
toms and signs. Suggestions are made that this is particularly true for the
less severe grades of OA and that in more severe grades of OA pain is
more common. Still there are people with Kellgren and Lawrence (K&L)
grade 3 or 4 of OA in hip and knee that do not have pain in hip or knee. To
better understand the absence of pain in people with moderate or severe
OA, it is necessary to ﬁnd out determinants related to pain in people with
moderate to severe radiological OA. In this study, we determine which
determinants explain the pain in hip or knee in people with Kellgren and
Lawrence grade 3 or 4 in knee or hip.
Methods: Participants in this study were participants of the Rotterdam
study, which included from 1990 onwards all inhabitants of 55 years
and older living in Ommoord, a district in Rotterdam. The aim of the
Rotterdam study was to investigate determinants of disease occurrence
and progression of chronic disabling diseases. All participants have had
an interview, an examination and x-rays.
We identiﬁed all participants who hade moderate to severe OA (K&L
grade 3 or 4) in hip or knee. Univariate logistic regression was used
to analyze the association between pain and moderate to severe OA of
knee or hip. Patient characteristics and variables for co-morbidity, health
status, depression, widespread pain, other symptoms of osteoarthritis,
familial OA, and bilaterality were tested.
Results: There were 7983 men and women participating in the Rotterdam
Study, of which 6450 visited the research centre for baseline examination.
Of 3035 participants the x-ray of the knees and 3320 x-rays of the hips
were scored with K&L. We identiﬁed 164 participants with moderate to
severe OA (K&L grade 3 or 4), 99 participants had pain in knee or hip and
65 participants had no pain in knee or hip. In univeriate logistic regression
analysis pain in knee or hip is associated with morning stiffness (OR 3.9,
p = 0.000), bilateral knee OA grade 3 or 4 (OR=3.0, p = 0.038), health
complaint (OR=3.0, p = 0.001).
Conclusions: Morning stiffness, bilateral knee OA, and health complains
are indicators for having pain with moderate to severe OA. These deter-
minants are all indicators of disease and cannot explain the absence of
pain with moderate to severe OA. Maybe an explanation for the absence
in pain can be found in genetic research. Another limitation of this study
is that a lot of possible determinants are not measured in this cohort, for
example physical activity. The sample size of this study was very small
and there were only 65 cases.
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Purpose: To establish an objective and accurate quantiﬁcation method of
the structural severity of knee osteoarthritis (OA), we have developed a
computer program KOACAD (knee OA computer-aided diagnosis) which
for the ﬁrst time has realized a fully automatic measurement of major OA
parameters on plain knee radiographs (OA&C 2008). The present study
sought to identify radiographic factors that predict the future progression
of pain in knee OA patients by applying the KOACAD system to the NIH
Osteoarthritis Initiative (OAI) public data.
Methods: This study used the progression subcohort data in the OAI
(public-use dataset 0.C.1), since all subjects in the subcohort were knee
OA patients with frequent knee symptoms and radiographic knee OA.
From 814 subjects, 722 without knee surgery (292 men and 430 women,
average 61.8 yrs.) who completed the WOMAC scores at baseline and
24-month follow-up surveys were enrolled. More than 20% increase of
the WOMAC knee pain score during the follow-up period was deﬁned
as the progression of knee pain. On plain anteroposterior radiographs
at the baseline, we measured the six major OA parameters: medial and
lateral joint space area (JSA), medial and lateral minimum joint space
width (mJSW), osteophyte area, and tibiofemoral angle (TFA), using
the KOACAD system. The non-paired t-test was used to examine the
difference of age, gender, body mass index (BMI), and the KOACAD
parameters between the groups with and without the knee pain progres-
sion. Furthermore, odds ratio (OR) and the associated 95% conﬁdence
interval (CI) were determined using logistic regression analysis after
adjustment for age, gender and BMI. A p-value of <0.05 for analysis
of safety variables was considered signiﬁcant.
Results: The mean WOMAC pain score was 4.1 (range: 0−19) at
the baseline and 3.8 (0−18) at the 24-month follow-up, and the mean
change was −0.3 (−13±10). In the overall 722 patients, 46 (14 men
and 32 women) showed the knee pain progression. There was no
signiﬁcant difference of age, gender, and BMI between the groups with
and without the pain progression (46 vs. 676). Among the KOACAD
parameters at the baseline, medial JSA (93.6±5.7 for progression vs.
92.3±1.4mm2 for non-progression; mean±S.D.), lateral JSA (102.8±6.8
vs. 113.5±1.7mm2), medial mJSW (2.6±0.2 vs. 2.8±0.1mm), os-
teophyte area (1.1±1.0 vs. 2.7±0.2mm2), and TFA (176.3±0.2 vs.
176.5±0.6 degree) were not signiﬁcantly different between the two
groups; however, lateral mJSW (3.3±0.5 vs. 4.3±0.1mm) was signiﬁ-
cantly lower in the group with the knee pain progression (p = 0.0083).
Logistic regression analysis after adjustment for age, gender and BMI
conﬁrmed that low lateral mJSWwas associated with the pain progression
(OR=1.24, 95%CI = 1.04−1.46). The association was stronger in women
(OR=1.32, 95%CI = 1.05−1.68) than in men (OR=1.13, 95%CI =
0.94−1.41).
Conclusions: Utilizing the KOACAD system and the OAI public data, we
have found that lateral joint space narrowing on plain radiographs, but not
medial joint space narrowing, osteophytosis or knee angulation, can be a
predictive parameter of the pain progression in knee OA patients. Inter-
estingly, our previous cross-sectional study using the KOACAD showed
signiﬁcant association of medial joint space narrowing, but not lateral joint
space narrowing, with the presence of knee pain in a normal population-
based cohort, implicating a distinct etiology between the incidence and
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progression of knee pain. The KOACAD system will be useful for objective
evaluation of the disease severity in daily clinical practice, just as bone
mineral density is in osteoporosis.
467 NEUROPATHIC PAIN SYMPTOM MEASURES STRIKE A
NERVE IN OSTEOARTHRITIS
J. Hochman1, D. Sutton1, M. French1, L. Gagliese2, A. Davis3,
G. Hawker1. 1Women’s College Hospital, Toronto, ON, CANADA,
2University Health Network, Toronto, ON, CANADA, 3Toronto Western
Hospital Research Institute, Toronto, ON, CANADA
Purpose: Pain is the most common, disabling symptom for people
with Osteoarthritis (OA). Cumulative data suggests dysfunctional pain
processing by the central nervous system, called central sensitization
(CS), contributes to pain in OA. CS can be associated with the neuro-
pathic pain (NP) symptom proﬁle including burning, electric-shock like
sensations, and sensitivity to light touch. Improved understanding of pain
mechanisms in OA, including development of “clinically feasible” tools to
identify individuals likely to have CS would facilitate development of novel
mechanism-based pain therapies. This ongoing study is assessing (1) NP
symptoms in subjects with symptomatic knee OA, using a NP question-
naire modiﬁed for use in OA, the modiﬁed painDETECT (mPD-Q), and the
Self-completed Leeds Assessment of Neuropathic Symptoms and Signs
pain scale (S-LANSS), which has been validated in other chronic pain
populations; (2) pain intensity, using the Von Korff Chronic Pain Grade
Scale (CPG) and, (3) co-morbid chronic pain and neurological conditions.
Methods: Eligible study subjects are members of an existing population-
based OA cohort with chronic symptomatic knee OA deﬁned by pain,
discomfort and/or stiffness in the knee(s) on most days for  3 months.
A standardized questionnaire was mailed to 268 cohort members to date,
to assess (1) pain quality for each knee using the mPD-Q, scored -1 to
38; and the S-LANSS, scored 0−24; (2) pain intensity, using the CPG,
scored 0–100; and (3) co-morbid conditions. Mean, median, and standard
deviation (SD) were evaluated for questionnaire scores. The proportion of
knee OA cohort participants with mPD-Q and S-LANSS scores in the ‘NP
range’ (mPD-Q score 19, S-LANSS score 12) was calculated using a
95% conﬁdence interval. Pearson correlations between mPD-Q and other
questionnaire scores (SLANSS and CPG) were examined.
Results: To date, 129 (48%) questionnaires have been returned. Thirty-
two (29%) responders reported no chronic knee pain. Among 92 (71%)
responders with chronic knee pain, 73 had chronic right and 63 had
chronic left knee pain. Mean (SD) mPD-Q scores were the same, 12 (7),
for right and left knees. Mean (SD) S-LANSS scores were 8 (8) for right
knees and 7 (7) for left knees. According to cut-points identiﬁed in other
pain populations, the proportion (95%CI) of study subjects with scores in
the ‘NP range’ on the mPD-Q was 0.21 (0.12−0.32) for right knees and
0.17 (0.08−0.28) for left knees; on the S-LANSS was 0.31 (0.20−0.42) for
the right knees and 0.25 (0.14−0.36) for left knees. The mPD-Q scores
had a moderate to high correlation with the S-LANSS scores for right
(r = 0.68) and left knees (r = 0.73). The mPD-Q scores had a moderate
correlation with CPG pain intensity scores for right (r = 0.61) and left
(r = 0.65) knees. The following factors did not explain the variability seen
in mPD-Q scores: presence of diabetes, another chronic pain condition,
a co-morbid neurological condition.
Conclusions: In a population-based cohort with chronic knee OA, almost
a quarter of subjects with painful knee OA scored in the ‘NP range’ on
both of the measures assessed. This subgroup of patients may beneﬁt
from further evaluation for NP likely due to CS and consideration of NP
medications. Further validation work on the mPD-Q is ongoing.
468 FURTHER VALIDATION OF OARSI-OMERACT INTERMITTENT
AND CONSTANT OSTEOARTHRITIS PAIN (ICOAP) MEASURE
G.A. Hawker1, M.R. French1, A.M. Davis2, P. Dieppe3. 1Women’s
College Hospital, Toronto, ON, CANADA, 2Toronto Western Research
Institute, Toronto, ON, CANADA, 3University of Oxford, Oxford, UNITED
KINGDOM
Purpose: To further assess the construct validity of ICOAP, a new
osteoarthritis (OA) pain measure.
Methods: The new measure, ICOAP, is comprised of 5 items assessing
‘constant’ hip or knee pain and 6 items assessing ‘intermittent’ hip or
knee pain; item response options are on a 4-point scale from ‘not at all’
to ‘extremely’. Subscale and total scores are standardized to 0 to 100,
where higher scores indicate worse pain. The ICOAP was administered
by phone to an established community cohort aged 55+ years with
moderate to severe hip and/or knee OA. All subjects completed both
the hip and knee versions of the ICOAP, regardless of which joints were
painful at the time. Participants also completed other measures of arthritis
pain and disability (WOMAC pain, function and stiffness subscales;
McGill pain intensity scale, and the limitation dimension of the Late
Life Function and Disability Instrument), the Proﬁle of Mood States-Brief
(POMS) fatigue/inertia scale, the SF-36 general health perception scale,
the CES-D scale for depressed mood, the Lubben Social Network Scale,
and the Pain Catastrophizing Scale. Summary descriptive statistics were
calculated for all scale scores. Spearman’s rho correlation coefﬁcients
were calculated to assess the relationship between ICOAP Hip and Knee
subscale and total scores with each of the other measures. T-tests were
used to compare means ICOAP scores for men versus women.
Results: The mean age of the 659 participants was 77.6 years (58.7 to
97.9), 77.4% were female and 23.7% had < high school education; 631
had complete data for ICOAP Hip and 608 for ICOAP Knee. Mean score
(SD) for the hip was 26.8 (SD 25.0) and 18.0 (SD 26.8) for intermittent and
constant pain, respectively. For the knee, mean intermittent and constant
pain scores were 30.9 (SD 23.3) and 16.0 (SD 26.5), respectively. Women
had higher intermittent and total ICOAP pain scores than men (hip and
knee results similar, p< 0.05 for all). Within individuals, intermittent and
constant pain scores were only modestly correlated (r = 0.29 for the knee;
r = 0.46 for the hip, p< 0.0001 for both) and their strength of association
with other measures differed (e.g. correlation with pain catastrophizing
score: intermittent pain r = 0.27 versus constant pain r = 0.39). For the
hip, measures of coping, fatigue, mood and physical functioning were
more strongly related to constant than to intermittent pain. For the
knee, the reverse was generally true, with stronger correlations being
associated with intermittent knee pain scores. ICOAP score correlations
with WOMAC pain scores ranged from 0.39 (hips; ICOAP intermittent
pain) to 0.65 (knees; ICOAP total pain). Higher scores for both intermittent
and constant pain were associated with lower general health status,
higher scores on other pain and disability measures, higher scores for
depression, fatigue and pain catastrophizing, and lower scores for social
support.
Conclusions: Our results provide further evidence of the ICOAP as a
valid tool for evaluation of pain in hip and knee OA and supports use of
the two subscale scores for intermittent and constant pain independently
as distinct and important domains of OA pain.
469 C-REACTIVE PROTEIN LEVELS ARE ASSOCIATED WITH
OA-RELATED KNEE PAIN IN WOMEN
H.J. Kerkhof, M. Sharma, S. Bierma-Zeinstra, H.A. Pols,
A.G. Uitterlinden, J.B. van Meurs. Erasmus Medical Center, Rotterdam,
NETHERLANDS
Purpose: Four previous studies (n = 1675) have shown that C-Reactive
Protein (CRP) levels are associated with (progression of) knee os-
teoarthritis (KOA). At this moment, there are only three studies (n = 968)
published, examining the relationship between CRP levels and joint
complaints or disability. In this population-based study, we analyzed the
association between CRP levels and KOA-related knee pain and the
relationship between CRP levels, body mass index (BMI) and KOA since
it is still not clear whether BMI plays a role as a confounder or as effect
mediator in this model.
Methods: In total, 1655 women from the Rotterdam Study had data
on radiographic knee OA, age, BMI and CRP levels. High-sensitivity
CRP measurements were performed using rate near-infrared particle
immunoassay. For all statistical analysis, log-transformed CRP values
were used. KOA was deﬁned as a Kellgren/Lawrence score 2 in one
or both knees. Knee pain was deﬁned as having pain in the right or left
knee during the last month or the past ﬁve years.
Results: Women with knee OA had 30% higher CRP levels compared
to women without KOA (p = 8×10−7), but after adjustment for age and
BMI this association disappeared (p = 0.3). We next stratiﬁed our data
according to BMI, to investigate the role of BMI as an effect modiﬁer. We
observed that women with a BMI< 27.0 kg/m2 and with KOA had 34%
higher levels of CRP compared to women without KOA (p = 0.004 after
adjustment for age and co-morbidity). Importantly, this association was
absent in women with a BMI> 27.0 kg/m2 (p = 0.63). CRP levels were
borderline signiﬁcant associated with an increased risk of knee pain in
our study (p = 0.053 after adjustment for age and BMI). This effect was
only visible in women with radiographic KOA (27% higher CRP levels,
p = 0.03 after adjustment for age and BMI) and not in women without
KOA (p = 0.43).
